Clinical Study of Stent Versus Direct Atherectomy to Treat Lower Limb Ischemia
1 other identifier
interventional
120
1 country
1
Brief Summary
This is a randomized study comparing stent and plaque excision systems in treatment of lower limb (superficial femoral or popliteal artery) ischemia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2014
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 31, 2015
CompletedFirst Posted
Study publicly available on registry
August 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedJuly 13, 2016
December 1, 2015
2.2 years
July 31, 2015
July 11, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
12-month Primary Patency Rate
Primary patency is defined as no significant reduction of flow detectable by Duplex ultrasound through the index lesion and no further clinically driven target vessel revascularization performed in the interim. Significant reduction of flow is binary restenosis defined as the diameter stenosis \>50% with a peak systolic velocity ratio \>2.4 as measured by Duplex ultrasound.
12 months
12-month Limb Salvage Rate
Limb Salvage is defined as the freedom from secondary major amputation
12 months
Secondary Outcomes (3)
Index Limb Ischemia at 6-month Follow up
6 months
Index Limb Ischemia at 12-month Follow up
12 months
Major Adverse Events at 12-month Post Procedure
12 months
Study Arms (2)
Intervention: Stents
ACTIVE COMPARATORStents group
Intervention: Atherectomy
ACTIVE COMPARATORDirect Atherectomy group
Interventions
Eligibility Criteria
You may qualify if:
- Provides written informed consent Willing to comply with follow-up evaluations at specified times Has claudication or rest pain due to peripheral arterial disease Disease located within the femoropopliteal artery Patient has a de novo or restenotic lesion(s) with \>50% stenosis documented angiographically and no prior stent in the target lesion.
- Patient has symptoms of peripheral arterial disease classified as Rutherford Category 2 or greater.
You may not qualify if:
- Previously implanted stent(s) or stent graft(s) in target leg Life expectancy less than 12 months Has any planned surgical or endovascular intervention of target vessel 30 days before or after index procedure Thrombophlebitis, uremia, or deep venous thrombus, within past 30 days. Receiving dialysis or immunosuppressant therapy. Recent stroke within past 90 days. Known allergies to the following: aspirin, clopidogrel bisulfate (Plavix®) or ticlopidine (Ticlid®), heparin, Nitinol (nickel titanium), contrast agent, that cannot be medically managed.
- Tissue loss due to ischemic disease (Rutherford/Becker category 5 or 6) Serum creatinine level \>/= 2.5 mg/dl at time of screening visit Known or suspected active infection at the time of the procedure Bleeding diathesis Patient is unwilling or unable to comply with procedures specified in the protocol or has difficulty or inability to return for follow-up visits as specified by the protocol.
- Patient is known to be pregnant, incarcerated, mentally incompetent, and/or alcohol or drug abuser.
- Patient is currently participating in any other investigational drug or medical device study that has not completed primary endpoint(s) evaluation or clinically interferes with the endpoints from this study or future participation in such studies prior to the completion of this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gu Yong Quan
Beijing, Beijing Municipality, 100053, China
Related Publications (1)
Yongquan G, Lianrui G, Lixing Q, Xuefeng L, Zhu T, Shijun C, Yingfeng W, Jianming G, Jian Z, Zhonggao W. Plaque excision in the management of lower-limb ischemia of atherosclerosis and in-stent restenosis with the SilverHawk atherectomy catheter. Int Angiol. 2013 Aug;32(4):362-7.
PMID: 23822938BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 31, 2015
First Posted
August 3, 2015
Study Start
January 1, 2014
Primary Completion
March 1, 2016
Study Completion
April 1, 2016
Last Updated
July 13, 2016
Record last verified: 2015-12